Practical Recommendations in Immuno and Molecular Oncology (PRIMO)
February 5-8, 2025
Honolulu, HI
Accreditation and Credit Statements
In support of improving patient care, The Medical Educator Consortium is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 12.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physician
The Medical Educator Consortium designates this live activity for a maximum of 12.00 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
“Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.”
Learner participation will be shared through the ACCME’s Program and Activity Reporting System (PARS)
Nursing
The Medical Educator Consortium designates this activity for 12.00 contact hours.
ILNA Coding:
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points as follows:
- Care Continuum (OCN, CBCN, CPHON, A0CNP): 12.0 points
- Care of the Pediatric Hematology and Oncology Patient (CPHON): 1.5 points*
- Cellular Collection, Preparative Regimens, and Infusion (BMTCN): 1.5 points*
- Coordination of Care (CBCN): 2.5 points*
- Diagnosis and Staging (CBCN): 2.5 points*
- Early Post-Transplant Management and Education (BMTCN): 1.5 points*
- Foundations of Transplant (BMTCN): 1.5 points*
- Late Post-Transplant Management and Education (BMTCN) 1.5 points*
- Nursing Practice (CBCN): 2.5 points*
- Oncologic Emergencies (OCN, CPHON, AOCNP): 8.5 points*
- Oncology Nursing Practice (OCN): 12.0 points*
- Professional Practice/Performance (BMTCN, AOCNP): 8.5 point*
- Roles of the APRN (AOCNP): 5.5 point*
- Symptom Management, Palliative Care, Supportive Care (OCN, CPHON, AOCNP): 8.5 points*
- Transplant Process and Infusion (BMTCN): 1.5 points*
- Treatment (OCN, CBCN, AOCNP, CPHON): 8.5 points
Total Points: 12.0*
*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated is the maximum amount of points that can be claimed in each domain. The total amount of ILNA points claimed may not exceed the total amount of Nursing Continuing Professional Development (NCPD) awarded from this course and may only apply to the credential each nurse is renewing.
Disclaimer: ONCC review is only for designating content to be used for ILNA points and is not for NCPD accreditation. NCPD programs must be formally approved for contact hours by an acceptable accreditor/approver of nursing NCPD to be used for recertification by ONCC. If the NCPD provider fails to obtain formal approval to award contact hours by an acceptable accrediting/approval body, no information related to ONCC recertification or ILNA categories may be used in relation to the program.
Pharmacist
This Application-based activity has been approved for 12.00 contact hours (1.20 CEU) by The Medical Educator Consortium. The Universal Activity Number for this program is JA4008179-0000-25-001-L01-P. Your CE credits will be electronically submitted to CPE Monitor® within 60 days upon successful completion of the activity.
Physician Associate
The Medical Educator Consortium has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 12.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
DISCLOSURE POLICY
The Medical Educator Consortium (MEC) adheres to the Joint Accreditation Criteria and the ACCME Standards for Integrity and Independence in Accredited Continuing Education. As a Joint Accreditation (JA) provider, decisions in the planning process of this conference were made free of the control of ineligible companies. All persons that will be in a position to control the content of the CE Activity are required to disclose all relevant financial relationships, regardless of the amount, that they have had in the past 24 months with ineligible companies. MEC has implemented a mechanism to identify, mitigate and disclose relevant financial relationships prior to the education activity being delivered to learners. A Disclosure Index document outlining this information will be made available to participants prior to the educational activity. The source of all commercial support from ineligible companies will also be disclosed to learners prior to the beginning of the educational activity. CE activities must be balanced, independent of commercial bias, and designed to improve quality in health care. All recommendations involving clinical medicine must be based on evidence within the medical profession.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contradictions, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contradictions and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
